CTRI/2017/03/008162
Completed
Phase 4
CLINICAL EVALUATION OF THE TREATMENT OF CLASS II FURCATION INVOLVEMENTS WITH CALCIUM SULFATE HEMIHYDRATE IN NANOPARTICULATE FORM
I0 sites30 target enrollmentTBD
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Health Condition 1: null- systemically healthy subjects with Chronic Periodontitis
- Sponsor
- I
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •the presence of bilateral Class II furcation lesions (according to the classification given by Hamp et al, 1975\), with vertical probing depth \>5mm and horizontal probing depth \>4mm
Exclusion Criteria
- •exclusion of through and through lesions. Patients with any known medical condition, or on a therapeutic regimen that would decrease the probability of soft tissue or bone healing, pregnant patients, smokers, patients who had undergone periodontal surgery in the last six months or were under any other clinical trial, patients allergic to tetracycline, chlorhexidine and who had any antibiotic medication in the last three months, and those not willing to consent for treatment and subsequent follow\-up
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Evaluation of indirect restorationsClass II caries lesionsCAD/CAM,Ceramic Block,Hybrid Block,Indirect RestorationTCTR20191212002Erciyes University60
Active, not recruiting
Not Applicable
A PHASE II CLINICAL STUDY TO DETERMINE THE EFFICACY AND SAFETY OF DEPOCITE (CITARABINE LIPOSOMIALE INJECTON) FOR THE TREATMENT OF CNS RELAPSE IN ADULT PATIENTS WITH ACUTE LYMPOBLASTIC LEUKEMIA OR VERY RELAPSE IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA OR VERY AGGRESSIVE LYMPOMACNS RELAPSE IN ADULT PATIENT'S WITH ACUTE LYPHOBLASTIC LEUKEMIA O VERY AGGRESSIVE LYMPHOMAMedDRA version: 6.1Level: HLGTClassification code 10025322EUCTR2004-004082-15-ITAZIENDA OSPEDALIERA OSPEDALI RIUNITI DI BERGAMO (A.O. DI RILIEVO NAZIONALE)
Active, not recruiting
Not Applicable
A PHASE II CLINICAL STUDY TO DETERMINE THE EFFICACY AND SAFETY OF DEPOCYTE® (CYTARABINE LIPOSOME INJECTION) FOR THE TREATMENT OF CNS RELAPSE IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA OR HIGH-GRADE LYMPHOMA - DepoCyte® in ALL / NHL CNS relapseAcute lymphoblastic leukaemiaEUCTR2005-000173-21-ATDieter Hoelzer, MD,PhD20
Active, not recruiting
Phase 1
Phase II Trial for the Treatment of Advanced Classical Kaposi?s Sarcoma with the HIV Protease Inhibitor Indinavir in Combination with Chemotherapy - NDpatients with advanced Kaposi sarcoma, stage III/IVMedDRA version: 9.1Level: LLTClassification code 10023287Term: Kaposi's sarcoma classicalEUCTR2007-000567-26-ITISTITUTO SUPERIORE DI SANITA`25
Not yet recruiting
Phase 2
Comparison of two ayurvedic medicine in the patients suffering from skin diseaseHealth Condition 1: L20-L30- Dermatitis and eczemaCTRI/2019/10/021747Dr Babasaheb Rangrao Deshmukh